New eye drop could ease severe allergy in kids
NCT ID NCT07169695
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new eye drop called T1695 against an existing treatment (ciclosporin) for children aged 4 to 17 with moderate to severe vernal keratoconjunctivitis, a serious allergic eye condition. About 120 participants will use the drops for 4 weeks to see which better reduces corneal damage. The goal is to find a safer or more effective option for managing this chronic eye allergy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
T1695 eye drops
What this could lead to
If T1695 works better than ciclosporin, it could offer a new treatment option for children with severe eye allergies.
What could go wrong
This is an early Phase 2 trial with only 120 participants, so results may not confirm effectiveness. The condition can be serious, but the new drug may not prove superior or could have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE VERNAL KERATOCONJUNCTIVITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Agrawal Hospital
RECRUITINGJaipur, India
-
Disha Eye Hospitals - Barrackpore
RECRUITINGKolkata, West Bengal, India
-
L V Prasad Eye Institute
RECRUITINGVisakhapatnam, India
-
L. V. Prasad Eye Institute (LVPEI)
RECRUITINGHyderabad, India
-
M&J Institute of Ophthalmology
RECRUITINGAhmedabad, India
-
Narayana Nethralaya
RECRUITINGBangalore, India
-
Netralaya Super Speciality Eye Hospital
RECRUITINGAhmedabad, India
-
PBMA'S H. V. Desai Eye Hospital
RECRUITINGPune, India
-
Regional Institute of Ophthalmology (RIO) - Kolkata
RECRUITINGKolkata, India
-
Regional Institute of Ophthalmology, Patna
RECRUITINGPatna, India
-
Shivam Retina Clinic and Eye Hospital
RECRUITINGSurat, India